In this case, the outcome of the overall chemokine receptor modulation is less clear-cut; however, the downregulation of CX3CR1 suggests that the recruitment of cytotoxic CD56dim NK cells may be reduced in neuroblastoma lesions. Here, CX3CR1 is linked to neuroblastoma.